Wealthfront Advisers’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $685K | Sell |
10,941
-925
| -8% | -$57.9K | ﹤0.01% | 752 |
|
2025
Q1 | $714K | Buy |
11,866
+2,002
| +20% | +$121K | ﹤0.01% | 719 |
|
2024
Q4 | $576K | Sell |
9,864
-265
| -3% | -$15.5K | ﹤0.01% | 760 |
|
2024
Q3 | $600K | Buy |
10,129
+953
| +10% | +$56.4K | ﹤0.01% | 740 |
|
2024
Q2 | $514K | Sell |
9,176
-44
| -0.5% | -$2.47K | ﹤0.01% | 735 |
|
2024
Q1 | $540K | Buy |
9,220
+1,017
| +12% | +$59.6K | ﹤0.01% | 724 |
|
2023
Q4 | $443K | Sell |
8,203
-2,473
| -23% | -$133K | ﹤0.01% | 737 |
|
2023
Q3 | $518K | Buy |
10,676
+2,511
| +31% | +$122K | ﹤0.01% | 680 |
|
2023
Q2 | $461K | Sell |
8,165
-1,289
| -14% | -$72.8K | ﹤0.01% | 699 |
|
2023
Q1 | $510K | Sell |
9,454
-554
| -6% | -$29.9K | ﹤0.01% | 656 |
|
2022
Q4 | $526K | Buy |
+10,008
| New | +$526K | ﹤0.01% | 621 |
|
2022
Q3 | – | Sell |
-5,296
| Closed | -$267K | – | 772 |
|
2022
Q2 | $267K | Sell |
5,296
-3,727
| -41% | -$188K | ﹤0.01% | 707 |
|
2022
Q1 | $550K | Buy |
9,023
+256
| +3% | +$15.6K | ﹤0.01% | 614 |
|
2021
Q4 | $577K | Buy |
8,767
+1,045
| +14% | +$68.8K | ﹤0.01% | 568 |
|
2021
Q3 | $485K | Buy |
+7,722
| New | +$485K | ﹤0.01% | 563 |
|